139 related articles for article (PubMed ID: 7474673)
1. Calcium-regulated parathyroid hormone secretion in adynamic renal osteodystrophy.
Sanchez CP; Goodman WG; Ramirez JA; Gales B; Belin TR; Segre GV; Salusky IB
Kidney Int; 1995 Sep; 48(3):838-43. PubMed ID: 7474673
[TBL] [Abstract][Full Text] [Related]
2. Suppressive effect of calcium on parathyroid hormone release in adynamic renal osteodystrophy and secondary hyperparathyroidism.
Goodman WG; Veldhuis JD; Belin TR; Juppner H; Salusky IB
Kidney Int; 1997 May; 51(5):1590-5. PubMed ID: 9150477
[TBL] [Abstract][Full Text] [Related]
3. Direct in vivo comparison of calcium-regulated parathyroid hormone secretion in normal volunteers and patients with secondary hyperparathyroidism.
Ramirez JA; Goodman WG; Gornbein J; Menezes C; Moulton L; Segre GV; Salusky IB
J Clin Endocrinol Metab; 1993 Jun; 76(6):1489-94. PubMed ID: 8501155
[TBL] [Abstract][Full Text] [Related]
4. Calcium-regulated parathyroid hormone release in patients with mild or advanced secondary hyperparathyroidism.
Goodman WG; Belin T; Gales B; Juppner H; Segre GV; Salusky IB
Kidney Int; 1995 Nov; 48(5):1553-8. PubMed ID: 8544413
[TBL] [Abstract][Full Text] [Related]
5. Biochemical markers of renal osteodystrophy in pediatric patients undergoing CAPD/CCPD.
Salusky IB; Ramirez JA; Oppenheim W; Gales B; Segre GV; Goodman WG
Kidney Int; 1994 Jan; 45(1):253-8. PubMed ID: 8127016
[TBL] [Abstract][Full Text] [Related]
6. In vivo assessments of calcium-regulated parathyroid hormone release in secondary hyperparathyroidism.
Goodman WG; Belin TR; Salusky IB
Kidney Int; 1996 Dec; 50(6):1834-44. PubMed ID: 8943464
[TBL] [Abstract][Full Text] [Related]
7. Effect of CAPD and hemodialysis on parathyroid function.
Malberti F; Corradi B; Imbasciati E
Adv Perit Dial; 1996; 12():239-44. PubMed ID: 8865912
[TBL] [Abstract][Full Text] [Related]
8. The PTH-calcium curve and the set point of calcium in primary and secondary hyperparathyroidism.
Malberti F; Farina M; Imbasciati E
Nephrol Dial Transplant; 1999 Oct; 14(10):2398-406. PubMed ID: 10528664
[TBL] [Abstract][Full Text] [Related]
9. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
Lorenzo Sellares V; Torregrosa V
Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
[TBL] [Abstract][Full Text] [Related]
10. Reversal of adynamic bone disease by lowering of dialysate calcium.
Haris A; Sherrard DJ; Hercz G
Kidney Int; 2006 Sep; 70(5):931-7. PubMed ID: 16837920
[TBL] [Abstract][Full Text] [Related]
11. Parathyroid hormone changes during phosphorus load in patients with chronic renal insufficiency with low serum parathyroid hormone or adynamic bone disease.
Cuppari L; Carvalho AB; Lobão RR; Martini LA; Cendoroglo M; Ventura RT; Draibe SA
Clin Nephrol; 2001 Jul; 56(1):35-43. PubMed ID: 11499657
[TBL] [Abstract][Full Text] [Related]
12. Adynamic bone revisited: is there progress?
Sanchez CP
Perit Dial Int; 2006; 26(1):43-8. PubMed ID: 16538874
[TBL] [Abstract][Full Text] [Related]
13. In vivo studies of parathyroid gland function in secondary hyperparathyroidism.
Salusky IB; Goodman WG
Adv Nephrol Necker Hosp; 1996; 25():289-302. PubMed ID: 8717632
[TBL] [Abstract][Full Text] [Related]
14. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
15. Parathormone secretion in peritoneal dialysis patients with adynamic bone disease.
Carmen Sánchez M; Auxiliadora Bajo M; Selgas R; Mate A; Millán I; Eugenia Martínez M; López-Barea F
Am J Kidney Dis; 2000 Nov; 36(5):953-61. PubMed ID: 11054351
[TBL] [Abstract][Full Text] [Related]
16. Calcitriol therapy and calcium-regulated PTH secretion in patients with secondary hyperparathyroidism.
Ramirez JA; Goodman WG; Belin TR; Gales B; Segre GV; Salusky IB
Am J Physiol; 1994 Dec; 267(6 Pt 1):E961-7. PubMed ID: 7810641
[TBL] [Abstract][Full Text] [Related]
17. Development of adynamic bone in patients with secondary hyperparathyroidism after intermittent calcitriol therapy.
Goodman WG; Ramirez JA; Belin TR; Chon Y; Gales B; Segre GV; Salusky IB
Kidney Int; 1994 Oct; 46(4):1160-6. PubMed ID: 7861712
[TBL] [Abstract][Full Text] [Related]
18. Role of parathyroid hormone and therapy with active vitamin D sterols in renal osteodystrophy.
Hernandez JD; Wesseling K; Salusky IB
Semin Dial; 2005; 18(4):290-5. PubMed ID: 16076350
[TBL] [Abstract][Full Text] [Related]
19. Renal osteodystrophy and secondary hyperparathyroidism.
Fukagawa M; Kazama JJ; Kurokawa K
Nephrol Dial Transplant; 2002; 17 Suppl 10():2-5. PubMed ID: 12386262
[TBL] [Abstract][Full Text] [Related]
20. Calcium-sensing by parathyroid glands in secondary hyperparathyroidism.
Goodman WG; Veldhuis JD; Belin TR; Van Herle AJ; Juppner H; Salusky IB
J Clin Endocrinol Metab; 1998 Aug; 83(8):2765-72. PubMed ID: 9709944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
